{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:25:52Z","timestamp":1789413952400,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Young Talent Research and Development Program of the First Affiliated Hospital of Nanchang University","award":["YFYPY202410"],"award-info":[{"award-number":["YFYPY202410"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160140"],"award-info":[{"award-number":["82160140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87126-0","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:14:35Z","timestamp":1737530075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Study on the correlation between serum IgG4\/IgG levels and the development of Graves\u2019 ophthalmopathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuanyuan","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxia","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-3576","authenticated-orcid":false,"given":"Jixiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"87126_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.disamonth.2015.09.008","volume":"61","author":"A Sarkar","year":"2015","unstructured":"Sarkar, A. & Pitchumoni, C. S. The protean manifestations of IgG4-RD in gastrointestinal disorders. Dis. Mon. 61, 493\u2013515 (2015).","journal-title":"Dis. Mon"},{"key":"87126_CR2","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace, Z. S. et al. IgG4-Related disease: clinical and Laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 67, 2466\u20132475 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"87126_CR3","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1530\/EJE-19-0154","volume":"181","author":"E Diamanti-Kandarakis","year":"2019","unstructured":"Diamanti-Kandarakis, E. et al. DIAGNOSIS OF ENDOCRINE DISEASE: drug-induced endocrinopathies and diabetes: a combo-endocrinology overview. Eur. J. Endocrinol. 181, R73\u2013R105 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"87126_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone, J. H., Zen, Y. & Deshpande, V. IgG4-related disease. N Engl. J. Med. 366, 539\u2013551 (2012).","journal-title":"N Engl. J. Med."},{"key":"87126_CR5","doi-asserted-by":"publisher","first-page":"b34","DOI":"10.1210\/jendso\/bvab034","volume":"5","author":"C Dosiou","year":"2021","unstructured":"Dosiou, C. & Kossler, A. L. Thyroid Eye Disease: navigating the New Treatment Landscape. J. Endocr. Soc. 5, b34 (2021).","journal-title":"J. Endocr. Soc."},{"key":"87126_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/cen.14296","volume":"93","author":"YH Chin","year":"2020","unstructured":"Chin, Y. H. et al. Prevalence of thyroid eye disease in Graves\u2019 disease: a meta-analysis and systematic review. Clin. Endocrinol. (Oxf). 93, 363\u2013374 (2020).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"87126_CR7","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1089\/thy.2017.0126","volume":"27","author":"SH Yu","year":"2017","unstructured":"Yu, S. H. et al. Clinical implications of Immunoglobulin G4 to Graves\u2019 Ophthalmopathy. Thyroid 27, 1185\u20131193 (2017).","journal-title":"Thyroid"},{"key":"87126_CR8","doi-asserted-by":"publisher","first-page":"1083321","DOI":"10.3389\/fendo.2023.1083321","volume":"14","author":"M Olejarz","year":"2023","unstructured":"Olejarz, M. et al. High IgG4 serum concentration is associated with active Graves orbitopathy. Front. Endocrinol. (Lausanne). 14, 1083321 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"87126_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1167\/iovs.61.5.57","volume":"61","author":"H Ye","year":"2020","unstructured":"Ye, H. et al. Elevated immunoglobulin G4 levels in patients with thyroid Eye Disease and their clinical implications. Invest. Ophthalmol. Vis. Sci. 61, 57 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"87126_CR10","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s40618-023-02265-3","volume":"47","author":"S Comi","year":"2024","unstructured":"Comi, S. et al. IgG4 serum levels in Graves\u2019 orbitopathy. J. Endocrinol. Invest. 47 (7), 1711\u20131717 (2024).","journal-title":"J. Endocrinol. Invest."},{"key":"87126_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11596-013-1167-y","volume":"33","author":"W Sun","year":"2013","unstructured":"Sun, W., Gao, R. F., Chen, Y., Su, Y. Y. & Dong, L. L. Measurement of serum IgG4 levels by an established ELISA system and its clinical applications in autoimmune diseases. J. Huazhong Univ. Sci. Technolog Med. Sci. 33, 611\u2013614 (2013).","journal-title":"J. Huazhong Univ. Sci. Technolog Med. Sci."},{"key":"87126_CR12","first-page":"e124233","volume":"10","author":"Y Su","year":"2015","unstructured":"Su, Y. et al. Detection of serum IgG4 levels in patients with IgG4-related disease and other disorders. PLoS One. 10, e124233 (2015).","journal-title":"PLoS One"},{"key":"87126_CR13","first-page":"580814","volume":"2012","author":"Y Masaki","year":"2012","unstructured":"Masaki, Y. et al. Cutoff values of serum IgG4 and histopathological IgG4\u2009+\u2009plasma cells for diagnosis of patients with IgG4-Related disease. Int. J. Rheumatol. 2012, 580814 (2012).","journal-title":"Int. J. Rheumatol."},{"key":"87126_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5603\/EP.2016.0061","volume":"67","author":"D Dutta","year":"2016","unstructured":"Dutta, D., Ahuja, A. & Selvan, C. Immunoglobulin G4 related thyroid disorders: diagnostic challenges and clinical outcomes. Endokrynol Pol. 67, 520\u2013524 (2016).","journal-title":"Endokrynol Pol."},{"key":"87126_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s12020-021-02935-3","volume":"75","author":"Y Deng","year":"2022","unstructured":"Deng, Y., Wang, J., Zou, G., Liu, Z. & Xu, J. The characteristics and clinical significance of elevated serum IgG4\/IgG levels in patients with Graves\u2019 disease. Endocrine 75, 829\u2013836 (2022).","journal-title":"Endocrine"},{"key":"87126_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","volume":"119","author":"GB Bartley","year":"1995","unstructured":"Bartley, G. B. & Gorman, C. A. Diagnostic criteria for Graves\u2019 ophthalmopathy. Am. J. Ophthalmol. 119, 792\u2013795 (1995).","journal-title":"Am. J. Ophthalmol."},{"key":"87126_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1530\/eje.1.02230","volume":"155","author":"WM Wiersinga","year":"2006","unstructured":"Wiersinga, W. M. et al. Clinical assessment of patients with Graves\u2019 orbitopathy: the European Group on Graves\u2019 Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur. J. Endocrinol. 155, 387\u2013389 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"87126_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"L Bartalena","year":"2008","unstructured":"Bartalena, L. et al. Consensus statement of the European Group on Graves\u2019 orbitopathy (EUGOGO) on management of GO. Eur. J. Endocrinol. 158, 273\u2013285 (2008).","journal-title":"Eur. J. Endocrinol."},{"key":"87126_CR19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12020-016-1157-5","volume":"55","author":"CS Martin","year":"2017","unstructured":"Martin, C. S. et al. Serum immunoglobulin G4 levels and Graves\u2019 disease phenotype. Endocrine 55, 478\u2013484 (2017).","journal-title":"Endocrine"},{"key":"87126_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/a-0669-9333","volume":"128","author":"I Hiratsuka","year":"2020","unstructured":"Hiratsuka, I. et al. Changes in serum immunoglobulin G4 levels in patients with newly diagnosed Graves\u2019 Disease. Exp. Clin. Endocrinol. Diabetes. 128, 119\u2013124 (2020).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"87126_CR21","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/cen.12671","volume":"83","author":"E Bozkirli","year":"2015","unstructured":"Bozkirli, E. et al. Serum immunoglobulin G4 levels are elevated in patients with Graves\u2019 ophthalmopathy. Clin. Endocrinol. (Oxf). 83, 962\u2013967 (2015).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"87126_CR22","doi-asserted-by":"publisher","first-page":"20220694","DOI":"10.1515\/biol-2022-0694","volume":"18","author":"J Zhao","year":"2023","unstructured":"Zhao, J., Ge, Y., Li, W. & Jiang, Z. Clinical significance of the detection of serum IgG4 and IgG4\/IgG ratio in patients with thyroid-associated ophthalmopathy. Open. Life Sci. 18, 20220694 (2023).","journal-title":"Open. Life Sci."},{"key":"87126_CR23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cell.2016.10.026","volume":"167","author":"L Chen","year":"2016","unstructured":"Chen, L. et al. Genetic drivers of epigenetic and transcriptional variation in Human Immune cells. Cell 167, 1398\u20131414 (2016).","journal-title":"Cell"},{"key":"87126_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","volume":"15","author":"HM Knochelmann","year":"2018","unstructured":"Knochelmann, H. M. et al. When worlds collide: Th17 and Treg cells in cancer and autoimmunity. Cell. Mol. Immunol. 15, 458\u2013469 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"87126_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/annrheumdis-2016-209139","volume":"76","author":"T Maehara","year":"2017","unstructured":"Maehara, T. et al. Lesional CD4\u2009+\u2009IFN-gamma\u2009+\u2009cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis. Ann. Rheum. Dis. 76, 377\u2013385 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"87126_CR26","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2169\/internalmedicine.56.7824","volume":"56","author":"K Torimoto","year":"2017","unstructured":"Torimoto, K. et al. Clinical features of patients with Basedow\u2019s Disease and high serum IgG4 levels. Intern. Med. 56, 1009\u20131013 (2017).","journal-title":"Intern. Med."},{"key":"87126_CR27","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s40618-023-02085-5","volume":"46","author":"MM Saric","year":"2023","unstructured":"Saric, M. M. et al. The phenotype of Graves\u2019 orbitopathy is associated with thyrotropin receptor antibody levels. J. Endocrinol. Invest. 46, 2309\u20132317 (2023).","journal-title":"J. Endocrinol. Invest."},{"key":"87126_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1172\/JCI114768","volume":"86","author":"AP Weetman","year":"1990","unstructured":"Weetman, A. P. et al. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J. Clin. Invest. 86, 723\u2013727 (1990).","journal-title":"J. Clin. Invest."},{"key":"87126_CR29","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1210\/jc.2003-032068","volume":"89","author":"F Latrofa","year":"2004","unstructured":"Latrofa, F. et al. Affinity-enrichment of thyrotropin receptor autoantibodies from Graves\u2019 patients and normal individuals provides insight into their properties and possible origin from natural antibodies. J. Clin. Endocrinol. Metab. 89, 4734\u20134745 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"87126_CR30","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1089\/thy.2013.0448","volume":"24","author":"K Takeshima","year":"2014","unstructured":"Takeshima, K. et al. Elevated serum immunoglobulin G4 levels in patients with Graves\u2019 disease and their clinical implications. Thyroid 24, 736\u2013743. https:\/\/doi.org\/10.1089\/thy.2013.0448 (2014).","journal-title":"Thyroid"},{"key":"87126_CR31","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/joim.13524","volume":"292","author":"L Bartalena","year":"2022","unstructured":"Bartalena, L. & Tanda, M. L. Current concepts regarding Graves\u2019 orbitopathy. J. Intern. Med. 292, 692\u2013716 (2022).","journal-title":"J. Intern. Med."},{"key":"87126_CR32","doi-asserted-by":"publisher","first-page":"1124417","DOI":"10.3389\/fimmu.2023.1124417","volume":"14","author":"Y Tsuji","year":"2023","unstructured":"Tsuji, Y. et al. Identification of risk factors for elevated serum IgG4 levels in subjects in a large-scale health checkup cohort study. Front. Immunol. 14, 1124417 (2023).","journal-title":"Front. Immunol."},{"key":"87126_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10067-021-05772-x","volume":"41","author":"HC Tsai","year":"2022","unstructured":"Tsai, H. C. et al. Significance of high serum IgG4 in complete or non-full-fledged IgG4-related disease-a retrospective investigation of 845 patients and its clinical relevance. Clin. Rheumatol. 41, 115\u2013122 (2022).","journal-title":"Clin. Rheumatol."},{"key":"87126_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/03009742.2017.1363280","volume":"47","author":"S Liao","year":"2018","unstructured":"Liao, S. et al. Idiopathic retroperitoneal fibrosis: a cross-sectional study of 142 Chinese patients. Scand. J. Rheumatol. 47, 198\u2013205 (2018).","journal-title":"Scand. J. Rheumatol."},{"key":"87126_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ejim.2008.01.013","volume":"19","author":"C Daumerie","year":"2008","unstructured":"Daumerie, C., Duprez, T. & Boschi, A. Long-term multidisciplinary follow-up of unilateral thyroid-associated orbitopathy. Eur. J. Intern. Med. 19, 531\u2013536 (2008).","journal-title":"Eur. J. Intern. Med."},{"key":"87126_CR36","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1038\/s41433-020-01246-7","volume":"35","author":"B Du","year":"2021","unstructured":"Du, B., Wang, Y., Yang, M. & He, W. Clinical features and clinical course of thyroid-associated ophthalmopathy: a case series of 3620 Chinese cases. Eye (Lond). 35, 2294\u20132301 (2021).","journal-title":"Eye (Lond)"},{"key":"87126_CR37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10792-020-01571-6","volume":"41","author":"MN Naik","year":"2021","unstructured":"Naik, M. N. & Vasanthapuram, V. H. Demographic and clinical profile of 1000 patients with thyroid eye disease presenting to a Tertiary Eye Care Institute in India. Int. Ophthalmol. 41, 231\u2013236 (2021).","journal-title":"Int. Ophthalmol."},{"key":"87126_CR38","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s40618-020-01258-w","volume":"43","author":"P Perros","year":"2020","unstructured":"Perros, P. et al. Asymmetry indicates more severe and active disease in Graves\u2019 orbitopathy: results from a prospective cross-sectional multicentre study. J. Endocrinol. Invest. 43, 1717\u20131722 (2020).","journal-title":"J. Endocrinol. Invest."},{"key":"87126_CR39","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1080\/09273948.2020.1826537","volume":"30","author":"B Luo","year":"2022","unstructured":"Luo, B. et al. Ocular manifestations and clinical implications of serum immunoglobulin G4 levels in Graves\u2019 Ophthalmopathy patients. Ocul Immunol. Inflamm. 30, 580\u2013587 (2022).","journal-title":"Ocul Immunol. Inflamm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87126-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87126-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87126-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T18:56:32Z","timestamp":1737572192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87126-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87126"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87126-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"11 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards, and was approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University (Ethics number: 2018-063 and (2022)CDYFYYLK(09002)).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from patient\u2019s or legal guardians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"2770"}}